| Application no. and date | 16727089.1 (espacenet) (Federated) (European Patent Register), 20160523 | | Patent/reg. no. and date | DK/EP 3302502, 20190828 | | Publication date | 20180411 | | Priority no. and date | US 201562168449 P, 20150529, US 201562168470 P, 20150529, US 201562169309 P, 20150601, US 201562169321 P, 20150601, US 201662276767 P, 20160108 | | EP pub. no. and date |
EP 3302502 20180411 | | Effective date | | | Applicant/owner | Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100
Berkeley, CA 94710, US | | Applicant ref. no. | P81904298DK00E | | Inventor | GUIDUCCI, Cristiana, 1048 Talbot Avenue
Albany, California 94706, US,
COFFMAN, Robert L., 239 Echo Lane
Portola Valley, California 94028, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7125 (2006.01) , A61K 31/713 (2006.01) , A61P 35/00 (2006.01) , A61P 35/04 (2006.01) | | Title | Intrapulmonal administration af polynukleotid-agonister af toll-lignende receptor-9 til behandling af lungecancer | | Int. application no. | US2016033817 | | Int. publication no. | WO2016196062 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
